Universita Degli Studi Di Roma La Sapienza

At Universita Degli Studi Di Roma La Sapienza, research in nutritional and metabolic diseases and immune system diseases includes studies in IgA nephropathy and related kidney inflammation. These trials are designed to improve treatment choices, reduce proteinuria, and compare approaches that may better protect kidney function while limiting side effects.

• Targeted treatment strategies for idiopathic IgA nephropathy
• Comparing therapies aimed at lowering proteinuria and preserving renal health
• Evaluating safer ways to manage chronic kidney inflammation

Work at this site also reflects a strong interest in tailoring care to different patterns of kidney damage, helping clinicians choose more effective and better-tolerated options.

The site conducts extensive research in neoplasms, especially lymphomas, chronic lymphocytic leukemia, multiple myeloma, and myelofibrosis. These studies focus on testing new or extended-access treatments, improving disease control, and understanding long-term safety in patients with hematologic cancers.

• Therapies for marginal zone B-cell lymphoma and other non-Hodgkin lymphomas
• Treatment approaches for chronic lymphocytic leukemia and multiple myeloma
• Long-term management of primary myelofibrosis and related disorders

This research supports better disease control in blood cancers while exploring whether newer treatments can maintain benefit over time.

In the Department of Neurology at AO S. Andrea, trials address nervous system diseases such as radiologically isolated syndrome and spinocerebellar ataxia type 7. The main goals are to better understand disease progression, assess symptom stability, and evaluate whether proposed therapies can slow neurological decline.

• Studies in radiologically isolated syndrome to monitor new brain lesions
• Research on spinocerebellar ataxia type 7 to assess stability of movement and vision
• Exploring treatments that may help preserve neurological function

These studies combine clinical follow-up with a focus on improving diagnostic insight and treatment planning for progressive neurological conditions.

Research in skin and connective tissue diseases includes actinic keratosis and prevention of squamous cell carcinoma. The trials aim to test whether skin-directed treatments can lower cancer risk and improve long-term control of precancerous lesions.

• Managing actinic keratosis on the face or scalp
• Assessing prevention of invasive squamous cell carcinoma
• Comparing topical options to improve skin lesion outcomes

This area reflects a practical effort to reduce progression from common skin lesions to more serious disease.

Clinical trials in virus diseases and liver-related care include hepatitis B, hepatitis D, and acute-on-chronic liver failure. The research is aimed at improving antiviral control, supporting liver function, and reducing complications in patients with advanced liver disease.

• Evaluating treatment for hepatitis B and hepatitis D viral co-infection
• Studying therapies for acute-on-chronic liver failure
• Testing approaches that may improve survival and liver recovery

These studies address serious liver conditions where better supportive and disease-targeted therapies are urgently needed.

The site also investigates several neoplasms, including non-small cell lung cancer, glioblastoma, ovarian cancer, head and neck cancer, and prostate cancer. The purpose of these trials is to compare new treatment combinations with standard care and to improve disease control in difficult-to-treat cancers.

• Testing new options for HER2-mutated non-squamous non-small cell lung cancer
• Improving outcomes in glioblastoma and recurrent brain tumors
• Evaluating treatment strategies for ovarian cancer, head and neck cancer, and prostate cancer

At Universita Degli Studi Di Roma La Sapienza, this oncology research spans several cancer types and focuses on finding more effective ways to extend survival and control progression.

Research in hormonal diseases and nutritional and metabolic diseases includes hypogonadotropic hypogonadism and related reproductive hormone disorders. These studies examine whether hormone-based treatments can better support testosterone production and improve care for men with reduced gonadotropin activity.

• Assessing hormone replacement approaches in hypogonadotropic hypogonadism
• Comparing ways to restore normal reproductive hormone function
• Improving understanding of treatment response in male endocrine disorders

This work adds to the site’s broader interest in metabolic and hormonal conditions that affect quality of life and fertility.

The site contributes to bacterial infections and mycoses research through vaccine studies such as pneumococcal immunization. These trials are intended to evaluate immune response, strengthen prevention, and support better protection against serious bacterial disease.

• Studying pneumococcal vaccine responses in infants
• Supporting prevention of invasive bacterial infections
• Assessing immune protection in early life

This area highlights preventive medicine as an important part of the clinical trial portfolio at the site.